Beginning November 8, JPMorgan Chase & Co will no longer let its prime brokerage clients buy certain U.S. cannabis-related securities, according to a letter outlined by Reuters. The move follows similar actions by Credit Suisse last May. “J.P. Morgan (JPMS) has introduced a framework that is designed to comply with U.S. money laundering laws and […]
Some ancillary cannabis businesses are publicly traded on the New York Stock Exchange (NYSE). Cannabis stocks are not easy for investors to track or understand since the market is so volatile. The latest trends, news, and more on NYSE and cannabis are compiled below:
